Maze Therapeutics (MAZE) DMA 200 (2025 - 2026)

Maze Therapeutics (MAZE) DMA 200 (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) DMA 200
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 3.89
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 136.77
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 8.11
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 25.76
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 16.36
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 4.45
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 9.62
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 438.42
9 Abivax 90.15 Bn 90.15 Bn - 110.64
10 Maze Therapeutics 1.31 Bn 1.31 Bn 18.21 Mn 33.60

Historic Data

Download Data
DateValue
Jun 12, 2026 33.60
Jun 11, 2026 33.55
Jun 10, 2026 33.50
Jun 9, 2026 33.45
Jun 8, 2026 33.39
Jun 5, 2026 33.34
Jun 4, 2026 33.29
Jun 3, 2026 33.23
Jun 2, 2026 33.17
Jun 1, 2026 33.12
May 29, 2026 33.06
May 28, 2026 32.99
May 27, 2026 32.93
May 26, 2026 32.86
May 22, 2026 32.80
May 21, 2026 32.74
May 20, 2026 32.69
May 19, 2026 32.64
May 18, 2026 32.59
May 15, 2026 32.54